SOL Strategies

Phase A — Understand the business

Lens 1 · Company Overview

SOL Strategies makes money — and loses it — in four distinct ways, in descending order of what moves the equity:

1. Balance-sheet SOL (the treasury). The dominant driver of reported earnings and the share price. As of 30 Jun 2026: 460,017 SOL (~C$50.6M). This is down from ~533,040 SOL in Mar 2026 and ~390,000 SOL at the Sept 2025 CEO transition — the treasury has been shrinking, because SOL is being sold to service debt (see below). Reported net income is dominated by mark-to-market on this pile: SOL fell from ~$208 to ~$83 over H1 FY26, producing a $56.5M digital-asset revaluation loss + $21.7M–$22M of realized crypto losses.
2. Validator network (staking-as-a-service). SOL Strategies operates owned Solana validators (OrangeFin, Laine, Cogent) and takes a commission (typically 5–7% of inflation + MEV rewards on Solana) on third-party delegated stake. ~3,468,602 SOL under delegation across the network as of Jun 2026, serving ~33,106 unique wallets (>5% of all Solana stakers). This is the genuine operating business and the real differentiator vs. pure treasury peers.
3. STKESOL liquid-staking token. A liquid-staking derivative (LST): users deposit SOL, receive STKESOL, SOL Strategies stakes it and skims a fee. 646,528 SOL in STKESOL across 1,336 holders (Jun 2026, down from 768,022 SOL / 1,176 holders in Mar).
4. HoudiniSwap (fee revenue). Acquired 1 Jun 2026 for $18M ($4M in stock); a non-custodial, privacy-focused cross-chain swap aggregator. >$2.7B cumulative volume, >1.1M swaps; management guides $12–13M annual revenue and a ~$2.5M EBITDA floor. Plus the "Dark Lake" acquisition (Ziga zero-knowledge privacy tech). This is the "move up the stack to user-facing products" pivot.

Customers/counterparties: delegators to its validators (retail + institutions — ARK Invest's Digital Asset Revolutions Fund, VanEck, Crypto.com, Neptune Digital Assets, Solana Mobile are named ecosystem partners ); HoudiniSwap end-users; and, critically, ATW Partners — the convertible-note financier who is effectively the company's balance-sheet counterparty (see Lens 5/9).

Key contract term that defines the model — the ATW facility. Up to US$500M convertible note facility (signed 23 Apr 2025, initial $20M closed 1 May 2025). Capital is earmarked exclusively to buy SOL, which is then staked on SOL Strategies' own validators; interest is paid in SOL, calculated as up to 85% of the staking yield generated by the facility-funded SOL; notes convert at the prevailing market price the day before conversion. That last clause is the single most important structural fact in the whole dossier: a variable/floating conversion price means dilution scales up as the share price falls — the classic profile of a highly dilutive convertible.

`` corroboration: the 40-F confirms total long-term debt of C$60.6M (C$30.6M due <1yr, C$30.0M due 1–3yr), total contractual obligations C$62.96M, consistent with the ATW facility being drawn to ~$40–45M-equivalent.

Lens 2 · Supply Chain

The "supply chain" for a Solana treasury/validator company is a capital + protocol-yield chain, not a physical one. Named stakeholders end-to-end:

• Upstream capital → ATW Partners (convertible-note facility, the marginal SOL buyer) + equity markets (Nasdaq/CSE ATM-style issuance + the Guoga-era share base). This is where the SOL comes from.
• The asset → SOL token purchased on the open market (e.g. the initial tranche bought 122,524 SOL at avg $148.96 — now deeply underwater vs. ~$83 spot).
• Yield production → Solana L1 protocol (inflation rewards, currently ~4.3–4.7% network inflation declining 15%/yr toward 1.5%) + Jito (MEV tips, +20–40% on base rewards) + transaction fees. SOL Strategies' own validators (OrangeFin, Laine, Cogent) are the production nodes; 100% uptime, peak APY 5.84% / network-avg 5.53% delivered in Jun 2026.
• Custody / infrastructure → off-chain custodian(s) holding certain digital assets (the 40-F flags a material weakness precisely around "timely access to service organization control reports from a custodian that holds certain digital assets off-chain" ). Balance (Canadian custodian) integrated the OrangeFin validator as a staking provider.
• Distribution → delegators (retail wallets + institutions listed in Lens 1) and STKESOL holders; HoudiniSwap routes swap flow across chains.
• End "customer" → the SOL holder seeking yield, and the STKE shareholder seeking levered SOL exposure.

Chokepoints / single-source dependencies:

1. The SOL token price itself — the entire chain is one-factor. A 60% SOL drawdown (which happened) drops through unhedged.
2. ATW Partners — a single financier is the marginal capital source; the facility's floating conversion terms make the company a price-taker on its own dilution.
3. The custodian (off-chain) — flagged as a material-weakness point; a SOC-report gap is an audit and operational single point of failure.
4. Solana protocol governance — SIMD-0550 (accelerated disinflation) would compress the yield leg materially (see Lens 3/8/12).

Lens 3 · Competitive Advantages (moats)

The honest read: the moat is narrow and the premium moat is already gone.

• What's real: SOL Strategies has a genuine validator operating business — ~3.47M SOL under delegation, >5% of Solana stakers, 100% uptime, named institutional delegators, and now a liquid-staking token (STKESOL) and a consumer swap app (HoudiniSwap). That is more of an operating moat than a pure "hold SOL in a shell" treasury peer. CEO Michael Hubbard founded Laine (grew it to ~5.5M SOL delegated before selling it into SOL Strategies) — deep operator credibility on the validator side. The stated strategy is to move "up the stack from validator infrastructure to user-facing products and cross-chain liquidity" — i.e. build a fee moat that isn't purely SOL-beta.
• What's weak / gone:
• The mNAV premium — the reason a DAT exists — has inverted. STKE trades at ~0.92x mNAV (a discount to its crypto NAV) vs. DeFi Development Corp (DFDV) at ~1.8x. A DAT that trades below NAV has lost its capital-formation flywheel: it can no longer issue equity accretively to buy more SOL (issuing below NAV is dilutive to SOL-per-share). MicroStrategy's whole model requires a premium; STKE has the opposite.
• Sub-scale vs. the field. 460k treasury SOL is a fraction of Forward Industries (7.55M), Upexi (2.17M), DFDV (2.2M), Solana Company/HSDT (2.07M), Sharps (2.01M). In a "more DATs = valuation pressure" environment (Upexi's own CSO concedes greater supply weighs on multiples ), being the smallest treasury with the highest operating complexity is an awkward spot.
• Validator commission is not defensible. Solana validator commissions are a race to the bottom (0–10%, many at 0% to win delegation). No switching cost — delegators can re-delegate in one epoch.

Bargaining power: low on both sides. Over the SOL token: none (price-taker). Over ATW: weak (needs the capital; floating conversion favors the lender). Over delegators: weak (frictionless re-delegation). The only edge is reputation/uptime + Hubbard's ecosystem standing, which is real but not a wide moat.

Lens 4 · Segments

segments.csv is empty, so segment economics are reconstructed from the H1 FY26 disclosures and monthly updates — labeled accordingly. IFRS reporting folds crypto revaluation into the P&L, which swamps the operating segments:

Geography: HQ Toronto, Ontario; incorporated Ontario, Canada. Revenue is protocol-global (Solana is borderless); the entity is Canadian-domiciled, USD-reporting.

The tell: the only segment that produces GAAP-style operating revenue with a positive EBITDA floor is HoudiniSwap ($2.5M) — everything else is either non-cash token MTM or thin SOL-denominated staking fees. The six-month operating loss ex-revaluation was only ~$2.6M, so the operating business is close to breakeven — but the $77M of non-cash charges (revaluation + $12.1M validator write-down) is what defines the print.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest: H1 FY26, six months ended 31 Mar 2026)

The headline is a wreck, but disaggregation matters:

• Net loss: −$101.7M for the six months ended 31 Mar 2026. Composition:
• Digital-asset revaluation loss −$56.5M (SOL $208 → $83)
• Realized loss on crypto disposition −$21.7M / ~−$22M (selling SOL into a falling market to fund operations/debt)
• Validator write-down −$12.1M (impairment of the acquired validator goodwill/intangibles — the Laine-era M&A is already being marked down)
• Operating loss ex-revaluation ~−$2.6M
• Total non-cash ~$77M; ~$9M liability reduction
• Crypto holdings on balance sheet: $60.7M (Mar'26) vs $126.5M (Sept'25) — a ~52% halving of the core asset in two quarters.
• Balance-sheet flags: treasury is being liquidated to service debt — 65,001 SOL sold in June at C$87.88 to retire C$5.75M of debt. Long-term debt C$60.6M with C$30.6M due within 12 months against a treasury of only ~C$50.6M — i.e. near-term obligations exceed the liquid SOL pile. This is a self-liquidating balance sheet unless SOL rallies or new capital arrives.
• ICFR: material weaknesses disclosed (complex non-recurring transaction accounting; off-chain custodian SOC-report access), ICFR concluded not effective at FYE; remediation targeted by end of Q2 FY26. Auditor was changed (KRP resigned at company request Jan 2025 → Davidson & Company LLP), audit fees jumped C$149k → C$500k.
• Market reaction: brutal and sustained — STKE is down ~92% since its Nasdaq listing in Sept 2025; the sector (SOL DATs) is down 75–92% on a 34% SOL YTD decline. 52-week range $0.847–$14.72. This says the market is pricing STKE as a levered, dilutive SOL call option that is bleeding, not as a going-concern operating company.
• Consensus vs. actual: n/a — no meaningful sell-side EPS consensus for a token-MTM-driven micro-cap; the "beat/miss" frame doesn't apply. Next earnings 14 Aug 2026.

Lens 6 · Earnings Calls (sentiment trend)

transcripts/ is empty, so sentiment is drawn from the Q2 FY26 call summary + monthly updates + management commentary — labeled ``.

Tone arc: the narrative has visibly shifted from "accumulate SOL / grow the treasury" (2025) to "tighten, de-lever, and move up the stack to fee revenue" (2026). The Q2 FY26 call (CEO Hubbard) framed the pivot as moving "up the stack from validator infrastructure to user-facing products and cross-chain liquidity movement," integrating "token swaps and privacy products". Recurring 2026 themes: debt reduction, HoudiniSwap/Ziga integration, "tightening Solana focus." What management stopped saying: the aggressive "buy more SOL with the $500M facility" accumulation story of early 2025 — because issuing/converting below NAV now destroys SOL-per-share. The monthly updates are relentlessly on-message about uptime (100%), AUM, and holder counts — operational-proof-point framing that deliberately steers attention away from the treasury drawdown and the net loss. Net sentiment: defensive and transitional — a company managing a balance-sheet problem while trying to re-base the equity story on fees.

Lens 7 · Comps (Solana DAT peer set)

Multiples for these vehicles are mostly n/a — the peer set is loss-making token-MTM shells where P/E and EV/EBIT are meaningless. The relevant comp metric is mNAV (price vs. crypto NAV) and treasury scale:

• Market cap: STKE ~$50.8M (34.69M shares × ~$1.50). Revenue (TTM) reported −$8.78M and net income −$96.83M, EPS −$3.79 — note the negative "revenue" reflects IFRS crypto losses flowing through the top line.
• Dividend yield / 5-yr avg ROE: n/a (no dividend; ROE meaningless on a token-MTM base).
• The comp verdict: STKE is the only major SOL DAT trading below NAV while carrying the most operating complexity and debt. DFDV at 1.8x can still issue equity to buy SOL accretively; STKE at 0.92x cannot. That is the single most damning relative-value fact — the market is discounting STKE's management overhead and dilution risk against its own assets.

Lens 8 · Stock-Price Catalysts (moves >5%)

The pattern reveals STKE reacts to (a) the SOL token price above all, and (b) financing/dilution and treasury-accretion events — not to operating metrics:

• Sept 2025 — Nasdaq cross-listing (STKE): the "DAT++" debut; the stock has fallen ~92% since. Listing was the top; the premium compressed from there.
• Sept 22 / Oct 1 2025 — CEO Leah Wald steps down, Michael Hubbard (Laine founder) named interim (later permanent) CEO. Leadership-transition overhang.
• Throughout 2026 — SOL collapse $208 → $83 (−~60%): the dominant driver; sector-wide SOL DATs −75–92%.
• Apr–May 2025 — the $500M ATW convertible facility (initial $20M, 122,524 SOL @ $148.96): initially read as bullish accumulation; in hindsight the top-tick SOL buy + dilution mechanism.
• Jun 2026 — HoudiniSwap close ($18M) + debt reduction: the "up the stack / de-lever" pivot; modest relief but stock still slid ~6% on the June update.
• Insider signaling — Tony Guoga (ex-Chair, largest holder) buying on-market (250,000 shares Jul 2025; 138 buys vs 14 sells over 5 yrs) — a persistent insider-accumulation signal against the tape.

What the market actually reacts to: SOL price (beta ~1.5) and anything touching dilution/NAV. Operating proof-points (uptime, AUM, holder counts) move it little — confirming the equity is traded as a levered SOL instrument.

---

Phase C — Judge people & books

Lens 9 · Management

• Michael Hubbard — CEO (permanent, confirmed Q2 FY26; interim from Oct 2025) & signing as Interim CFO on the 40-F. Founder of Laine, a Solana validator he grew to ~5.5M SOL delegated before selling it into SOL Strategies. Track record: genuine, ecosystem-native operator — building and scaling a validator is the exact competence this company needs. Red flag: he is simultaneously CEO and Interim CFO — a concentration of the two most important control roles in one person at a company that has already disclosed material weaknesses in ICFR. That is a governance yellow-flag, especially given the auditor change (KRP → Davidson).
• Leah Wald — former CEO (departed Oct 1 2025). Prior CEO of Valkyrie Investments (first Nasdaq bitcoin-futures ETF). Led the Cypherpunk-Holdings → SOL-treasury transformation + Nasdaq listing, then left "having accomplished the objectives". Reads as a specialist brought in to execute the pivot and the listing, then exit — clean on paper, but a CEO leaving right at the top-tick before a 92% drawdown is a pattern worth noting.
• John Matonis — Chairman (appointed 2026, cypherpunk/e-cash pedigree); Luis Berruga (ex-Global X CEO) on the board/audit committee; Ungad Chadda audit-committee chair & financial expert.
• Antanas "Tony" Guoga (Tony G) — founder-era Chairman, now Strategic Advisor & largest shareholder. Built the vehicle from Cypherpunk Holdings; stepped down as Chair Jul 2025 but keeps buying on-market (was ~21–24% pre-transaction; ~6M shares reported more recently after heavy dilution). Skin in the game: high and increasing — the one genuinely bullish governance signal.
• Capital-allocation history — mixed-to-poor on timing. The core allocation decisions destroyed value in hindsight: bought SOL at ~$149 (initial ATW tranche) now worth ~$83; acquired validators (Laine et al.) that are now being written down ($12.1M impairment); and is now force-selling SOL at ~C$88 to service the debt taken on to buy it higher. The 2026 pivot (HoudiniSwap, de-lever) is a rational course-correction, but it follows a top-tick accumulation cycle.
• Founder vs. professional: a founder-adjacent, ecosystem-native operator (Hubbard) layered over a founder-owner (Guoga) — good for Solana credibility, but the combined-CFO role + ICFR weaknesses mean the controls maturity lags the ambition.

Lens 10 · Forensic Red Flags

Acting as a forensic analyst. This balance sheet has several genuine flags:

1. Material weaknesses in ICFR (self-disclosed). Two, both material: (a) no formal process to account for significant, complex, non-recurring transactions (i.e. the crypto M&A and treasury accounting — the exact area that produces the $77M of charges); (b) inability to get timely SOC reports from an off-chain custodian holding digital assets. ICFR concluded not effective at FYE Sept 30 2025. For a company whose entire balance sheet is digital assets, a custody-controls weakness is not cosmetic.
2. Auditor change mid-cycle. KRP resigned at the company's request (Jan 29 2025); Davidson & Company LLP appointed; audit fees C$149k → C$350k (FY24 re-audit) → C$500k (FY25). Auditor turnover + a fee 3x jump around a re-audit is a standard yellow-flag cluster.
3. Revaluation/realized-loss magnitude vs. tiny operating base. $77M+ of non-cash and realized crypto losses on a ~$2.6M operating loss — the reported number is ~97% "not the business." Investors must model this as a token vehicle, and the mark-to-market cuts both ways violently.
4. Validator intangible/goodwill impairment ($12.1M). The acquired validators are already being written down — the M&A that built the "moat" is impairing within a year. Watch for further goodwill writedowns if AUM/commission economics deteriorate (SIMD-0550).
5. Debt maturity vs. liquid assets. C$30.6M due within 12 months vs ~C$50.6M treasury, while the treasury is being sold down — a going-concern-adjacent liquidity setup even if not yet formally flagged.
6. Dilution via floating-conversion converts. ATW notes convert at the price the day before conversion — as the stock falls, share count balloons (23.0M shares at FYE Sept'25 → 34.69M by Jul'26, +~50%). This is the mechanical value-transfer from equity holders to the note holder.

Regulatory findings (required).

• SEC Litigation Releases: None — no LR naming SOL Strategies in the 2021-07-06 → 2026-07-06 window.
• AAERs: None found in the same window.
• Non-SEC enforcement (web search — "SOL Strategies" FTC/DOJ/FDA/CFPB/consent-decree/settlement/fine/penalty): no material enforcement actions, consent decrees, or fines surfaced as of 2026-07-06. (Note: as a foreign private issuer, STKE is exempt from Exchange Act §§14/16 and files 40-F/6-K, not 10-K/10-Q/DEF 14A — so U.S. insider (Form 4/5) and proxy disclosure is lighter than for domestic filers.)
• 10-K Item 3 (Legal Proceedings): n/a — as a 40-F filer there is no Item 3; the 40-F cover discloses no off-balance-sheet arrangements and lists contractual obligations (debt) only. Material litigation, if any, would sit in the AIF (Exhibit 99.1) not ingested here.
• Net: No SEC LR/AAER and no non-SEC enforcement found via SEC EDGAR EFTS (LR, AAER), web search, and the 40-F cover disclosures as of 2026-07-06. The forensic risk here is accounting-controls maturity and dilution mechanics, not regulatory enforcement.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

A conventional EPS projection is the wrong tool — reported earnings are ~97% SOL mark-to-market, so "EPS" is a leveraged bet on the SOL price path, not an operating forecast. I project the two things that actually matter: (a) SOL-per-share trajectory (the real per-share value of the vehicle) and (b) operating cash-burn / runway. All outputs `` with arithmetic shown.

Anchors: 460,017 treasury SOL; 34.69M shares; ~3.47M SOL delegated at ~5–7% commission on ~5.5% yield; HoudiniSwap ~$12–13M rev / ~$2.5M EBITDA floor; C$60.6M debt (C$30.6M <1yr); SOL spot ~$83.

(a) SOL-per-share = 460,017 / 34,690,000 = ~0.0133 SOL/share. Scenarios over ~2 years:

• Bear: continued below-NAV issuance + forced SOL sales to service debt → treasury shrinks to ~350k SOL, shares grow to ~45M via converts → ~0.0078 SOL/share (−41%). Even if SOL rallies, per-share exposure erodes.
• Base: debt managed down with HoudiniSwap cash + modest SOL sales, share count ~38M, treasury ~420k SOL → ~0.0111 SOL/share (−17%).
• Bull: SOL rallies hard, mNAV re-rates back above 1.0x, company issues accretively + validator AUM compounds, treasury ~520k SOL on ~36M shares → ~0.0144 SOL/share (+8%), plus optionality on the fee business.

(b) Operating runway: operating loss ex-revaluation ~$2.6M / 6mo → $5.2M/yr burn, now partly offset by HoudiniSwap ($2.5M EBITDA floor) → net operating burn ~$2.7M/yr. That is survivable from operations; the existential pressure is the ~C$30.6M debt due within 12 months against a shrinking C$50.6M treasury — the company must sell ~30–40% of its SOL, refinance, or raise equity to clear it. This, not EPS, is the number to model.

Forecast log: skipped per --watchlist rules (no forecast.ts create in the breadth loop). The base-case binary worth tracking if promoted: "STKE retires or refinances its FY26-due debt without a going-concern qualification in the FY26 40-F" — a balance-sheet survival question, not an EPS line.

Lens 12 · Bull vs Bear

Bull case. STKE is a discounted, actively-managed SOL proxy with a real operating business the market is giving away for free. At 0.92x mNAV you buy SOL below spot plus a validator network commanding >5% of Solana stake, a growing liquid-staking token, and a newly-acquired cash-generative swap app ($2.5M EBITDA floor). Leadership is ecosystem-native (Hubbard built Laine); the largest shareholder (Guoga) is buying on-market. If SOL re-rates in the next cycle, the equity is a levered call with an embedded yield engine — SOL-per-share × a re-expanding mNAV × operating-fee optionality. The 2026 pivot "up the stack" (HoudiniSwap, privacy tech) is a credible attempt to build value that isn't pure token beta. Contrarian view the market is refusing to see: the validator + fee business could eventually be worth more than the treasury, at which point STKE re-rates as an operating Solana-infrastructure company, not a discounted shell.

Bear case (2–3 permanent-impairment risks).

1. The flywheel is broken and may not restart. A DAT below NAV can't issue accretively — its core growth mechanism is dead. If mNAV stays <1.0x, STKE is a melting ice cube: forced SOL sales to service debt permanently shrink SOL-per-share, and dilutive converts compound the erosion. This is already happening (390k→460k treasury with a mid-cycle drawdown; shares +50%).
2. Yield compression via SIMD-0550. The staking-yield leg — the reason the whole model produces cash — is exposed to Solana governance doubling the disinflation rate (15%→30%/yr), projected to push staking yields to ~4.34% → 3.00% → 2.25% over three years. That halves the economic engine of both the treasury (staking income) and the validator commission business.
3. Balance-sheet/liquidity break. C$30.6M due <1yr vs a shrinking C$50.6M treasury, ICFR not effective, floating-conversion converts — a sharp further SOL leg-down forces asset sales at the worst prices and risks a going-concern qualification.

Pre-mortem (18 months out, thesis broke): SOL chopped sideways-to-down, mNAV stayed at ~0.8x, the company sold ~40% of its treasury and issued heavily via converts to clear the FY26 debt wall, SOL-per-share fell ~40%, HoudiniSwap fees ($2.5M) proved immaterial against the token losses, and STKE became a sub-$30M micro-cap perpetually diluting. The validator AUM stagnated as SIMD-0550 compressed commissions and delegators chased 0%-fee validators.

Are multiples too high? No — the equity is already below NAV. The risk isn't over-valuation, it's value leakage (dilution + forced sales) and SOL beta. This is a cheap-but-melting situation, not an expensive one.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case. The bull says "SOL below spot + free operating business." The short says:

• You're not buying SOL below spot — you're buying a leaking bucket of SOL wrapped in debt and dilution. The "discount" is the market correctly pricing (i) floating-conversion converts that transfer value to ATW as the stock falls, (ii) forced treasury liquidation to meet a C$30.6M near-term debt wall, and (iii) an ICFR that management itself says is not effective. A discount to NAV on a vehicle that is actively shrinking its NAV-per-share is not cheap — it's a value trap.
• Revenue concentration = 100% on one token. ~97% of the reported result is SOL mark-to-market. There is no diversification; a further SOL drawdown drops straight through, and the debt is fixed while the asset is not.
• The moat is a mirage. Validator commissions are a race to zero (0%-fee competitors), STKESOL is losing holders (768k→646k SOL QoQ), and the treasury is sub-scale vs. Forward (7.55M), Upexi, DFDV. The "up-the-stack" pivot (HoudiniSwap) is a $2.5M EBITDA floor — a rounding error against $77M of quarterly charges.
• Most dangerous competitor bulls underestimate: DFDV (and Forward). DFDV trades at 1.8x mNAV — it retains the capital-formation flywheel STKE has lost, so it out-accumulates SOL per share every quarter while STKE dilutes. In a DAT shakeout, capital consolidates to the premium names; the discounted, indebted, sub-scale one is the consolidation target or casualty, not the winner.
• Worst capital allocation: bought SOL at ~$149 with borrowed money, is selling it at ~$88 to repay that money, and wrote down the validators it bought to build the "moat." That is buy-high-sell-low with leverage.
• Assumptions that must hold for today's price: SOL doesn't leg down further before the FY26 debt is refinanced; mNAV re-rates above 1.0x to restore accretive issuance; SIMD-0550 fails or is delayed; ICFR gets remediated without a restatement. If growth/SOL disappoints 20–30% from here, the debt wall + dilution mechanics could force a distressed recapitalization — the classic permanent-impairment path for a levered DAT.

Lens 14 · Management Questions (ordered by information value)

1. The C$30.6M of debt due within 12 months exceeds your ~C$50.6M treasury while you're a net seller of SOL — exactly how do you clear it: asset sales, refinancing, or equity, and at what assumed SOL price? (The survival question.)
2. Your stock trades at ~0.92x mNAV. Below NAV you can't issue equity accretively — what is the concrete plan to get mNAV back above 1.0x, and what do you do with the balance sheet until then?
3. The ATW notes convert at the prior-day market price. What is the current outstanding drawn balance, the fully-diluted share count under conversion at today's price, and the maximum dilution the facility can inflict?
4. ICFR was "not effective" at FYE on two material weaknesses. Are they remediated as of today, and can you assure investors there is no risk of restatement of the crypto-accounting or custody positions?
5. You wrote down validators by $12.1M within a year of acquiring them. What impairment triggers remain, and how do you justify the prices paid for Laine/OrangeFin/Cogent in hindsight?
6. SIMD-0550 could cut Solana staking yields to ~2.25% over three years. What does that do to your treasury staking income and your validator commission revenue, and how do you offset it?
7. Why is the CEO also serving as Interim CFO at a company with disclosed control weaknesses — when will a permanent, independent CFO be in place?
8. STKESOL holders and staked SOL both fell quarter-over-quarter (768k→646k). Is the liquid-staking product losing share, and to whom?
9. HoudiniSwap is guided to ~$2.5M EBITDA. Realistically, over what timeframe can fee revenue become large enough to matter against $50M+ swings in the treasury?
10. What is your hedging policy on the treasury? Given a fixed debt load against a volatile SOL position, why not hedge some downside?
11. Forward Industries (7.55M SOL) and DFDV (1.8x mNAV) are outgrowing you on SOL-per-share. What is your right to win as the smallest, most-levered, discounted DAT?
12. Your former CEO departed at what proved to be the top-tick before a 92% drawdown. What changed in strategy under the new leadership beyond "de-lever and move up the stack"?
13. What covenants, if any, attach to the ATW facility, and what happens on a breach or a sustained sub-$1 share price / delisting risk?
14. How much of the ~3.47M SOL under delegation is "sticky" institutional stake vs. yield-chasing retail that could re-delegate to a 0%-fee validator in one epoch?
15. If SOL is flat for 18 months, walk me through the equity value per share — treasury, debt, dilution, and fees — and tell me why it isn't a slow-motion wipeout.

---